| Product Information |
|
| Registration Number |
DR-XY47457
|
| Generic Name |
Ketoanalogues + Essential Amino Acids
|
| Brand Name |
Keamax
|
| Dosage Strength |
Each film-coated tablet contains: Calcium-4-methyl-2-oxo-valerate
101 mg L-Lysine acetate
105 mg (a-ketoanalogue to leucine, calcium salt) Calcium-3-methyl-2-oxo-butyrate
86 mg
L-Threonine
53 mg (a-ketoanalogue to valine, calcium salt) Calcium-2-oxo-3-phenylpropionate
68 mg
L-Histidine
38 mg (a-ketoanalogue to phenylalanine, calcium salt) Calcium-3-methyl-2-oxo-valerate
67 mg
L-Tyrosine
30 mg (a-ketoanalogue to isoleucine, calcium salt) Calcium-DL-2-hydroxy-4-(methylthio) butyrate 59 mg
L-Tryptophan
23 mg (a-ketoanalogue to methionine, calcium salt)
|
| Dosage Form |
Film Coated Tablet
|
| Classification |
Prescription Drug (RX)
|
| Pharmacologic Category |
-
|
| Packaging |
Alu/PVC/PVDC clear blister pack x 20's (Box of
100's)
|
| Manufacturer |
Hebei Tiancheng Pharmaceutical Co., Ltd
|
| Country of Origin |
China
|
| Trader |
|
| Importer |
Goodfellow Pharma Corporation
|
| Distributor |
Goodfellow Pharma Corporation
|
| Application Type |
-
|
| Issuance Date |
12 October 2021
|
| Expiry Date |
12 October 2026
|